NASDAQ: PXMDPaxmedica Inc Stock Ownership - Who owns Paxmedica?
Insider buying vs selling
Have Paxmedica Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Zachary Rome | Director | 2024-03-12 | 4,904 | $0.69 | $3.38kSell |
| David W. Hough | Chief Medical Officer | 2024-03-12 | 1,452 | $0.69 | $1.00kSell |
| Stephen Sheldon | CFO and COO | 2024-03-12 | 3,356 | $0.69 | $2.32kSell |
| John F. Coelho | Director | 2024-03-12 | 207 | $0.69 | $142.83Sell |
| Howard J. Weisman | Chief Executive Officer | 2024-03-12 | 2,927 | $0.69 | $2.02kSell |
| Karen Larochelle | Director | 2024-03-12 | 604 | $0.69 | $416.76Sell |
| Charles J. Casamento | Director | 2024-03-12 | 992 | $0.69 | $684.48Sell |
| David W. Hough | Chief Medical Officer | 2024-02-21 | 291 | $0.66 | $191.77Sell |
| Stephen Sheldon | CFO and COO | 2024-02-21 | 243 | $0.66 | $160.14Sell |
| Zachary Rome | Director | 2024-01-29 | 811 | $0.48 | $389.28Sell |
PXMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PXMD insiders and whales buy or sell their stock.
PXMD Shareholders
What type of owners hold Paxmedica Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tardimed Sciences LLC | 99.04% | 7,336,745 | $5.08M | Insider |
| Michael Derby | 6.17% | 457,224 | $316.40k | Insider |
| Virtu Financial LLC | 0.76% | 56,441 | $39.06k | Institution |
| Howard J. Weisman | 0.47% | 34,748 | $24.05k | Insider |
| Citadel Advisors LLC | 0.38% | 27,973 | $19.36k | Institution |
| Stephen Sheldon | 0.15% | 11,243 | $7.78k | Insider |
| Two Sigma Securities LLC | 0.15% | 11,148 | $7.71k | Institution |
| Zachary Rome | 0.14% | 10,244 | $7.09k | Insider |
| Tower Research Capital LLC Trc | 0.09% | 6,747 | $4.67k | Institution |
| David W. Hough | 0.08% | 5,905 | $4.09k | Insider |
PXMD vs Biotech Stocks
Paxmedica Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.